Telo Genomics Corp. (the Company or TELO) announced the appointment of Guido Baechler as chairman of the Company's Board of Directors. Mr. Baechler first joined the TELO Board of Directors on February 28, 2019 as an independent director and assumed the role of lead director on December 5, 2019. He is an international life science executive with over 25 years of experience in the commercialization of medical diagnostics. The Company is also pleased to welcome John Meekison to the TELO Board of Directors. Mr. Meekison joined the Company's board at its most recent annual general meeting, and he has since been appointed chair of the Audit Committee. Mr. Meekison is an experienced investment banker, public and private company CFO, and Chartered Professional Accountant (CPA). Hugh Rogers has resigned as chairman and will remain a director of the Company.